USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
Michigan Critical Care Consultants, Inc.
Address:
3550 West Liberty
Suite 3
Ann Arbor, MI
Phone:
(734) 995-9089
URL:
EIN:
382667222
DUNS:
806687406
Number of Employees:
10
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,837,199.00 23
SBIR Phase II $12,312,526.00 15
STTR Phase I $1,285,003.00 8
STTR Phase II $2,525,983.00 3

Award List:

LOW HEMOLYSIS BLOOD PUMP WITH INTEGRAL PRESSURE CONTROLS

Award Year / Program / Phase:
1991 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Montoya, Jean P , Principal Investigator
Abstract:
N/a

CO2 REMOVAL IN CLOSED LOOP VENTILATION SYSTEMS

Award Year / Program / Phase:
1992 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Jean P Montoya
Abstract:
A system that continuously removes carbon dioxide from exhaled gas without the use of calcium carbonate cyrstals will be developed. this system will allow for closed loop ventilation by removing the co2 from the expired gas, and therefore decrease the amount of stored oxygen required. also, it will… More

LOW HEMOLYSIS BLOOD PUMP WITH INTEGRAL PRESSURE CONTROLS

Award Year / Program / Phase:
1993 / SBIR / Phase II
Award Amount:
$477,945.00
Agency:
HHS
Principal Investigator:
Montoya, Jean P , Principal Investigator
Abstract:
A novel design and initial prototype of a blood pump used for extracorporeal circulation is presented. due to the unique design, the pump has important desirable properties not found in current drivers, the standard roller and the centrifugal pumps. these properties include inherent pressure… More

Automatic Control of Extracorporeal Life Support

Award Year / Program / Phase:
1993 / SBIR / Phase I
Award Amount:
$50,000.00
Agency:
HHS
Principal Investigator:
Scott I. Merz
Abstract:
N/a

Automatic Control of Extracorporeal Life Support

Award Year / Program / Phase:
1994 / SBIR / Phase II
Award Amount:
$400,000.00
Agency:
HHS
Principal Investigator:
Scott I. Merz
Abstract:
An automatic control system for extracorporeal gas exchange support is presented. A microcomputer-based data acquisition, analysis, and feedback control system will be developed to control extracorporeal oxygen delivery (by adjusting extracorporeal blood flow) and carbon dioxide removal (by… More

Totally Implantable Artificial Lung

Award Year / Program / Phase:
1995 / SBIR / Phase I
Award Amount:
$99,437.00
Agency:
HHS
Principal Investigator:
Jean Montoya
Abstract:
N/a

Totally Implantable Artificial Lung

Award Year / Program / Phase:
1997 / SBIR / Phase II
Award Amount:
$741,500.00
Agency:
HHS
Principal Investigator:
Jean Montoya
Abstract:
A totally implantable intrapleural artificial lung (AL) is presented. The AL is designed to fully spatients who require long term (more than one month) artificial gas exchange support necessary for tThe device will also provide a bridge to lung transplantation when lung recovery is impossible.… More

2D HOLLOW ARRAY SOLID MEMBRANE FOR BLOOD OXYGENATORS

Award Year / Program / Phase:
1997 / SBIR / Phase I
Award Amount:
$99,994.00
Agency:
HHS
Principal Investigator:
Montoya, jean p
Abstract:
N/a

ANTIPLATELET NITRIC OXIDE RELEASING POLYMER COATINGS

Award Year / Program / Phase:
1998 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Merz, Scott I
Abstract:
N/a

N/A

Award Year / Program / Phase:
1999 / SBIR / Phase II
Award Amount:
$750,081.00
Agency:
HHS
Principal Investigator:
Montoya jean p
Abstract:
N/a

NOVEL PUMP FOR TIDAL FLOW EXTRACORPOREAL SUPPORT

Award Year / Program / Phase:
1999 / SBIR / Phase I
Award Amount:
$99,998.00
Agency:
HHS
Principal Investigator:
Scott I. Merz
Abstract:
Not Available Connectorless interfaces for shipboard weapons would improve supportability and maintainability by reducing requirements to constrained access areas and provide corrosion avoidance/reduction. Connectors are often damaged during weapon/store transportation and handling, easily corrode… More

PORTABLE EXTRACORPOREAL RESUSCITATION CONSOLE

Award Year / Program / Phase:
1999 / SBIR / Phase I
Award Amount:
$95,235.00
Agency:
HHS
Principal Investigator:
Scott I. Merz
Abstract:
N/a

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Scott I. Merz
Abstract:
N/a

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase II
Award Amount:
$404,208.00
Agency:
HHS
Principal Investigator:
Scott I. Merz
Abstract:
N/a

NOVEL PUMP FOR TIDAL FLOW EXTRACORPOREAL SUPPORT

Award Year / Program / Phase:
2001 / SBIR / Phase II
Award Amount:
$386,110.00
Agency:
HHS
Principal Investigator:
Scott I. Merz
Abstract:
DESCRIPTION (Unedited Applicant's Abstract):Extracorporeal Circulation is used in several blood treatment applications, including hemodialysis, respiratory support, and blood warming/cooling. These procedures usually require two vascular access sites; one for draining blood… More

NOVEL PUMP FOR TIDAL FLOW EXTRACORPOREAL SUPPORT

Award Year / Program / Phase:
2001 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Scott I. Merz
Abstract:
DESCRIPTION (Unedited Applicant's Abstract):Extracorporeal Circulation is used in several blood treatment applications, including hemodialysis, respiratory support, and blood warming/cooling. These procedures usually require two vascular access sites; one for draining blood… More

Paracorporeal Artificial Lung Development

Award Year / Program / Phase:
2001 / STTR / Phase I
Award Amount:
$175,811.00
Agency:
HHS
Principal Investigator:
Research Institution:
UNIVERSITY OF TEXAS MEDICAL BRANCH
RI Contact:
N/A
Abstract:
DESCRIPTION (Verbatim from the Applicant's Abstract): Despite the widespread success and enthusiasm f single and double lung transplantation, demand for donor lungs has steadily outgrown supply. Currently, the average wait is two years, with 30 percent wait-list mortality. A… More

Variable compliance chamber to alter pulmonary impedance

Award Year / Program / Phase:
2001 / SBIR / Phase I
Award Amount:
$93,821.00
Agency:
HHS
Principal Investigator:
Sean D. Chambers
Abstract:
DESCRIPTION (Applicant's Abstract): A variable compliance chamber (VCC) is proposed that will maintain near normal pulmonary input impedance during the treatment of pulmonary disease. Pulmonary impedance is related to the total work (steady and pulsatile) that the right… More

VARIABLE COMPLIANCE CHAMBER TO ALTER PULMONARY IMPEDANCE

Award Year / Program / Phase:
2002 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): A variable compliance chamber (VCC) is proposed to control pulmonary input impedance during the treatment of pulmonary disease. Pulmonary impedance is related to the total work the right heart must pump against, and it is altered (primarily in the form of… More

AMBULATORY ARTERIOVENOUS CARBON DIOXIDE REMOVAL

Award Year / Program / Phase:
2002 / STTR / Phase I
Award Amount:
$196,374.00
Agency:
HHS
Principal Investigator:
Research Institution:
UNIVERSITY OF TEXAS
RI Contact:
N/A
Abstract:
DESCRIPTION (provided by applicant): Chronic Obstructive Pulmonary Disease (COPD) affects 15-17 million people in the United States and is the fourth leading cause of death in the U.S. When COPD reaches end-stage, hypercarbia, not hypoxia, usually limits the COPD patients' ability to ambulate. Lung… More

SIMPLIFIED TOTAL LIQUID VENTILATOR

Award Year / Program / Phase:
2002 / STTR / Phase I
Award Amount:
$185,643.00
Agency:
HHS
Principal Investigator:
Research Institution:
UNIV OF MICHIGAN
RI Contact:
N/A
Abstract:
The acute respiratory distress syndrome (ARDS) is a severe, life-threatening disease process, which affects approximately 150,000 patients per year with an associated 30-50 percent mortality rate. Periluorocarbons are inert, colorless, low surface tension liquids that can carry large… More

VARIABLE COMPLIANCE CHAMBER TO ALTER PULMONARY IMPEDANCE

Award Year / Program / Phase:
2002 / SBIR / Phase II
Award Amount:
$739,312.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): A variable compliance chamber (VCC) is proposed to control pulmonary input impedance during the treatment of pulmonary disease. Pulmonary impedance is related to the total work the right heart must pump against, and it is altered (primarily in the form of… More

Enhanced Nitric Oxide-Releasing Materials

Award Year / Program / Phase:
2003 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The goal of this study is to incorporate nitric oxide (NO)-releasing compounds into polymer formulations that can be used to improve the biocompatibility of blood-contact surfaces in intravascular and extracorporeal devices. Previous studies have demonstrated… More

Enhanced Nitric Oxide-Releasing Materials

Award Year / Program / Phase:
2004 / SBIR / Phase II
Award Amount:
$1,015,642.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The goal of this project is to develop a family of nitric oxide-releasing materials (NORM), formed by adding nitric oxide (NO) donor compounds to polymers. The enhanced NORM developed in Phase I of this effort released NO for a prolonged period of time, at… More

Treatment of Heart Disease with an Intraventricular Sac

Award Year / Program / Phase:
2004 / SBIR / Phase I
Award Amount:
$94,624.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The purpose of this project is to develop a diastolic volume limiting apparatus (divola) for treatment of advanced heart disease in humans. This technology is an entirely new method of treatment of heart disease, and may be used in both dilated and ischemic… More

Treatment of Heart Disease with an Intraventricular Sac

Award Year / Program / Phase:
2005 / SBIR / Phase II
Award Amount:
$979,380.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The purpose of this project is to develop a diastolic volume limiting apparatus (divola) for treatment of advanced heart disease in humans. This technology is an entirely new method of treatment of heart disease, and may be used in both dilated and ischemic… More

Arterial Cannula with Permissive Distal Perfusion

Award Year / Program / Phase:
2005 / SBIR / Phase I
Award Amount:
$100,270.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): A novel cannula design will be developed to provide distal perfusion during arterial cannulation. Arterial cannulation is common in several applications of extracorporeal blood processing. However, placement of a cannula in an artery risks tissue damage due to… More

Totally Implantable Artificial Lung: Studies for FDA

Award Year / Program / Phase:
2005 / SBIR / Phase I
Award Amount:
$0.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): With significant support from the NIH SBIR grant program (5R44HL53168), MC3 has successfully developed an artificial lung, called the BioLung(r). The BioLung(r) design is based on our patented, ultra-low pressure drop artificial lung technology. This device… More

Totally Implantable Artificial Lung: Studies for FDA

Award Year / Program / Phase:
2005 / SBIR / Phase II
Award Amount:
$2,463,744.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): With significant support from the NIH SBIR grant program (5R44HL53168), MC3 has successfully developed an artificial lung, called the BioLung(r). The BioLung(r) design is based on our patented, ultra-low pressure drop artificial lung technology. This device… More

Implantable Glucose Sensor with Prolonged Accuracy

Award Year / Program / Phase:
2006 / SBIR / Phase I
Award Amount:
$145,049.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The goal in this study is to fabricate an intravascular glucose sensor that functions accurately for 3 days in vivo. To do this, we will develop an outer membrane that facilitates the conversion of endogenous S- nitrosothiols to nitric oxide locally at the… More

Development of a Perfusion-induced Systemic Hyperthermia Delivery Apparatus

Award Year / Program / Phase:
2007 / STTR / Phase I
Award Amount:
$205,583.00
Agency:
HHS
Principal Investigator:
Research Institution:
UNIVERSITY OF TEXAS MEDICAL BR
RI Contact:
N/A
Abstract:
DESCRIPTION (provided by applicant): Lung cancer is the leading cause of cancer-related deaths in both men and women in the US today, responsible for 28% of all cancer-related deaths. Long-term prognosis for patients with advanced stage non- small cell lung cancer, present in 75% of new… More

Catheters Designed for Decreased Clotting and Infection

Award Year / Program / Phase:
2007 / SBIR / Phase I
Award Amount:
$116,619.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The goal is this study is to fabricate an intravascular dual-functioning catheter that prevents both clotting and infection. This will be accomplished by combining novel selenium (Se) chemistries with surface bound hepa rin. The goals of this phase I application… More

Arterial Cannula with Permissive Distal Perfusion

Award Year / Program / Phase:
2007 / SBIR / Phase II
Award Amount:
$748,630.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): A novel cannula design is proposed to provide distal perfusion during arterial cannulation. Arterial cannulation is common in several applications of extracorporeal blood processing, such as ArterioVenous Carbon Dioxide Removal (AVCO2R) treatment. AVCO2R is a… More

Stent Coating to Prevent Restenosis and Subacute Thrombosis

Award Year / Program / Phase:
2007 / SBIR / Phase I
Award Amount:
$159,618.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): This fast track SBIR application proposes the refinement and preclinical testing of a coating designed to inhibit restenosis and thrombosis in intravascular stents. The research plan will build on encouraging results fr om pilot animal studies with coated… More

A Compact, Cardiopulmonary Support Device

Award Year / Program / Phase:
2008 / STTR / Phase I
Award Amount:
$162,223.00
Agency:
HHS
Principal Investigator:
Research Institution:
N/A
RI Contact:
N/A
Abstract:
DESCRIPTION (provided by applicant): The objective of this Phase I grant is to develop and test a compact cardiopulmonary support device (CCSD). This device pumps, transfers gas, and warms blood. The CCSD is attached to the patient via venovenous (VV) or v enoarterial (VA) cannulation and supplies… More

Implantable glucose sensor with prolonged accuracy

Award Year / Program / Phase:
2008 / SBIR / Phase II
Award Amount:
$806,213.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The goal of this study is to fabricate an intravascular glucose sensor that functions accurately for 7 days in vivo. We will utilize a glucose membrane design devised in Phase I to develop a custom outer membrane that has covalently attached bioactive sites to… More

A Novel Pediatric Pulsatile Rotary Ventricular Pump

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$122,818.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): A novel Pediatric Pulsatile Rotary Ventricular (PRVP) pump will be researched for pediatric Cardiopulmonary Bypass surgery which offers physiologic pulsatile blood flow, inherently safe management of low extracorporeal volumes, highly accurate very low flow… More

Stent Coating to Prevent Restenosis and Subacute Thrombosis

Award Year / Program / Phase:
2008 / SBIR / Phase II
Award Amount:
$876,537.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): This fast track SBIR application proposes the refinement and preclinical testing of a coating designed to inhibit restenosis and thrombosis in intravascular stents. The research plan will build on encouraging results fr om pilot animal studies with coated… More

Simple Automatic Perfusion System for salvage after cardiac arrest

Award Year / Program / Phase:
2009 / SBIR / Phase I
Award Amount:
$94,861.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Extracorporeal support (ECPR) improves survival in resuscitation from cardiac arrest from 5% to 30%. Extracorporeal support facilitates the salvage of donor organs after cardiac death (DCD). The Institute of Medicine re port states that innovative methods to… More

A Novel Pediatric Pulsatile Rotary Ventricular Pump

Award Year / Program / Phase:
2009 / SBIR / Phase II
Award Amount:
$794,086.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): A novel, pulsatile, disposable pump (pediatric MPulse) will be researched for pediatric Cardiopulmonary Bypass surgery which offers physiologic pulsatile blood flow, inherently safe management of low extracorporeal volu mes, highly accurate very low flow control,… More

Hand-held Coagulation Function Profiler

Award Year / Program / Phase:
2009 / SBIR / Phase I
Award Amount:
$69,997.00
Agency / Branch:
DOD / ARMY
Principal Investigator:
Scott I. Merz, Research Engineer
Abstract:
A rugged, hand-held coagulation profile device, based on thromboelastometry, will be developed. Robust measurements under adverse conditions will be assured through a model-driven design approach that will maintain the functionality of current clinical devices while decreasing sensitivities to… More

Novel Device with Hemostatic Injection System to Control Post Biopsy Bleeding

Award Year / Program / Phase:
2009 / SBIR / Phase I
Award Amount:
$94,858.00
Agency:
HHS
Principal Investigator:
Philip M. Wong
Abstract:
DESCRIPTION (provided by applicant): In nephrology, the use of conventional percutaneous biopsy needles is associated with the risk of post biopsy bleeding. This has resulted in a preference for alternate, higher cost biopsy methods such as open (surgical) biopsy and transjugular biopsy. We are… More

Hand-held Coagulation Function Profiler

Award Year / Program / Phase:
2010 / SBIR / Phase II
Award Amount:
$729,138.00
Agency:
DOD
Principal Investigator:
Scott Merz, Research Engineer – (734) 995-9089
Abstract:
A rugged, hand-held coagulation function profiler (CFP), based on thromboelastometry, will be developed by a team with experience in development and commercialization of medical devices, in conjunction with clinical thrombosis experts. Robust measurements under adverse conditions will be assured to… More